Skip to main content
OpenTrials
Completed

NCT Number: NCT07095283

Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence

Stress urinary incontinence (SUI) is defined as the loss of the ability to hold urine after exertion, i.e., as a result of imbalances in intra-abdominal pressure, which directly affect the lower urinary tract. SUI has been shown to have a significant impact on the quality of life of those affected, impacting physical, social, and psycho-emotional aspects. Among the proposed treatments is a physiotherapeutic approach, which is offered as a less invasive and painless therapy with fewer adverse effects than pharmacological or surgical treatment. Pelvic floor muscle training (PFMT) is the most effective physiotherapeutic treatment for SUI, increasing the contractile capacity of the muscles and restoring stability throughout the pelvic diaphragm, thereby ensuring proper support of the pelvic organs. Radiofrequency (RF) therapy is currently being proposed as a therapeutic option that may offer certain advantages over those reported for photoplethysmography (PPMT). The potential benefits of RF therapy are attributed to its ability to stimulate collagen metabolism, thereby promoting tissue regeneration. Radiofrequency (RF) is a non-invasive and painless method that has the potential to yield analogous results to pelvic physical therapy (PPMT) as a standalone treatment or enhance the efficacy of PPMT when administered in conjunction with RF for stress urinary incontinence (SUI).

The objective of the present study is to analyse the effectiveness of PFMT and RF as single or combined treatments for SUI in women at Clínica Traña, a clinic specialising in the treatment of pelvic floor dysfunction in Costa Rica. Following the process of obtaining informed consent, patients will be offered a single or combined treatment of RF and/or PFMT. The strength of the pelvic floor muscles, pelvic function and the impact of pelvic dysfunctions on quality of life will be evaluated with a one-year follow-up after the conclusion of treatment.

The project possesses the facilities, equipment, and personnel necessary to ensure its viability, as well as proven clinical experience.

The scientific and technical impact of the proposed treatment protocol will be achieved by establishing an effective therapeutic strategy to address SUI. The social impact of SUI is significant, given its high prevalence and the fact that it has physical consequences as well as a negative impact on the social activities, work functions and emotions of women who suffer from it.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women over the age of 18 who meet the International Continence Society (ICS)
  • diagnostic criteria for SUI, which consists of involuntary leakage of urine during increased intra-abdominal pressure in the absence of bladder contractions such as coughing, sneezing, and other physical activities.

Exclusion criteria

  • diagnosis of urgent or mixed UI
  • diagnosis of pelvic organ prolapse
  • taking any treatment for UI
  • pregnancy
  • history of pelvic surgery, urinary tract infection, or diagnosed psychological disorders
  • presence of scars, malformations, abnormal pelvic masses, tissue irritation, or any other condition in the area that could be causing pelvic and urinary function problems

Treatment and study plan

Short International Consultation on Incontinence Questionnaire (ICIQ-SF)

Diagnostic Test

This is a self-administered questionnaire with four questions and a total score ranging from 0 [best] to 21 [worst] that identifies people with urinary incontinence and its impact on quality of life.

King's Health Questionnaire (KHQ)

Diagnostic Test

The KHQ is a self-administered instrument specifically designed to assess quality of life in women with UI. It consists of 21 items distributed across 9 dimensions: perception of overall health (1 item), impact of UI (1 item), limitations in daily activities (2 items), physical limitations (2 items), social limitations (2 items), personal relationships (3 items), emotions (3 items), sleep/energy (2 items), and severity of UI (5 items). The score range for each dimension is from 0 (lowest impact of UI and therefore best quality of life) to 100 (highest impact, worst quality of life). This questionnaire provides an overall value for the quality of life of the patient with UI (Overall Score-OS) and another specific value for each dimension on a scale with the following range: 0: Best possible quality of life - 100: Worst possible quality of life.

Ultrasound evaluation

Diagnostic Test

A two-dimensional (2D) ultrasound system with B-mode capability and cine-loop function, a 3.5 to 6 MHz curved convex probe transducer, was used for the perineal image. The examination will be performed in the dorsal lithotomy position, with the hips flexed and slightly abducted and the heels placed close to the buttocks, or in a standing position if necessary.

Sandvik Severity Index

Diagnostic Test

It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.

Oxford's scale

Diagnostic Test

The strength of the Pelvic floor muscles will be evaluated digitally using functional ultrasound and classified according to the Oxford scale.

Biofeedback

Diagnostic Test

Muscular (mmHg) and static strength (seconds); Fatigability or Dynamic Endurance (% and cmH₂O)

Other names: Muscular and static strength; Fatigability or Dynamic Endurance

Primary outcomes

  1. International Consultation on Incontinence Questionnaire (ICIQ-SF)

    Time frame: Pre - post intervention; after 3,6,12 months

    0 to 21 points, where higher scores indicate greater impact of incontinence

  2. King´s Health Questionnaire (KHQ)

    Time frame: Pre - post intervention; after 3,6,12 months

    0 to 100, where 0 indicates the best quality of life and 100 the worst

  3. ultrasound analysis: Resting aperture (Ar)

    Time frame: Pre - post intervention; after 3,6,12 months

    degrees

  4. ultrasound analysis: Opening during exertion (Ae)

    Time frame: Pre - post intervention; after 3,6,12 months

    degrees

  5. Opening difference (Ae-Ar)

    Time frame: Pre - post intervention; after 3,6,12 months

    degrees

  6. MUSCULAR STRENGTH

    Time frame: Pre - post intervention; after 3,6,12 months

    defined as the ability of tissue to generate tension based on its contractile capacity, being the best of three attempts to contract, assessed using the modified OXFORD scale

  7. Function of the pelvic floor muscles

    Time frame: Pre - post intervention; after 3,6,12 months

    The best of the three attempts is selected, graded as follows: 0 = no contraction, 1 = partial contraction, 2 = contraction of the pelvic floor muscles + contraction of related muscles, 3 = isolated contraction of the Pelvic floor muscles

  8. STATIC MUSCLE STRENGTH

    Time frame: Pre - post intervention; after 3,6,12 months

    the ability to maintain optimal contraction (isometric, tonic fibers) for as long as possible, measuring the seconds until fatigue sets in. ORDER: "contract and hold," taking the average of the three assessments.

  9. Fatigability or Dynamic Endurance

    Time frame: Pre - post intervention; after 3,6,12 months

    maximum number of contractions in a unit of time, taking 10 seconds as the average. ORDER: "contract as many times as possible and at the highest speed," with the measurement being the average of the three assessments.

  10. Oxford's Scale

    Time frame: Pre - post intervention; after 3,6,12 months

    allows the contractile capacity of the pelvic floor muscles to be assessed. It scores from 0 to 5, as follows: if there is no contraction, it is scored as 0; if the contraction is very weak, it is scored as 1; if the contraction is weak, it is scored as 2; if the contraction is moderate/with tension/and sustained, it is scored as 3; if the contraction is good and maintains tension with resistance, it is scored as 4; and if the contraction is strong and maintains tension against a resistant force, it is scored as 5.

  11. Sandvik Severity Index

    Time frame: Pre - post intervention; after 3,6,12 months

    It allows the severity of UI to be determined based on two questions. Interpretation based on the score is classified as follows: 1-2 mild UI, 3-6 moderate UI, 8-9 severe UI, 12 very severe UI.

Secondary outcomes

  1. age (years)

    Time frame: baseline

  2. BMI (Body mass index)

    Time frame: baseline

    kg / m²

  3. smoke

    Time frame: baseline

    yes/no

  4. alcohol consumption

    Time frame: baseline

    yes/no

  5. drug use

    Time frame: baseline

    yes/no

  6. full-term pregnancies

    Time frame: baseline

    Number

  7. natural childbirth

    Time frame: baseline

    yes/no

  8. cesarean sections

    Time frame: baseline

    yes/no

  9. tear

    Time frame: baseline

    yes/no

  10. abortion

    Time frame: baseline

    yes/no

  11. episiotomy

    Time frame: baseline

    yes/no

Sponsors and collaborators

Lead sponsor

Cardenal Herrera University

Other

Registry information

Official study title

Second-generation Radiofrequency Application and Specific Therapeutic Exercise as a Treatment for Stress Urinary Incontinence Due to Urethral Instability. Randomised Clinical Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 31, 2025
Registry last updated
Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.